Aidan Gomez
Co-Founder & CEO @ Cohere
Oxford, United States
Aidan Gomez is a seed investor at Cohere in Oxford focused on Artificial Intelligence and Software. Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Aidan Gomez invests in
Stages Aidan Gomez invests in
Countries Aidan Gomez invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2.8M–$12M
- Pre-Seed
- $1.8M–$3.5M
Investment Focus
Industry
- Artificial Intelligence 8 (47%)
- Software 5 (29%)
- Information Technology 3 (18%)
- Generative AI 2 (12%)
- Pharmaceutical 2 (12%)
Stage
- Seed 11 (65%)
- Pre-Seed 2 (12%)
- Series A 1 (6%)
- Funding Round 1 (6%)
Country
- United States 4 (24%)
- United Kingdom 2 (12%)
- Canada 1 (6%)
- Luxembourg 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Helical
|
Helical is an intermediary platform that offers bioinformaticians free access to the technologies from AI and biological computation. | $10M / Seed / Apr 13, 2026 | |
General Magic
|
OpenSesame is a plug-and-play tool that detects AI hallucinations and improves response accuracy for companies using LLMs. Our platform leverages context-based information to detect hallucinations in LLMs with precision. By ensuring accurate and error-free text generation, we provide a reliable solution for enhancing AI outcomes. | $7.2M / Seed / Feb 24, 2026 | |
Cheiron
|
PhnyX Lab is working under the concept of redefining biopharma workflow through AI-powered solutions. The industry celebrates breakthroughs in medicine—but behind the scenes, progress isn't slowed by science. It's hindered by fragmented data, bloated documentation, and disconnected workflows. With Cheiron, they are revolutionizing howpharma operates, turning chaos into clarity by unifying internal and external data within a single discovery platform. They are going beyond unified search to intelligent action and automation, powered by GenAI. | $4M / Seed / Aug 04, 2025 | |
|
General Magic
|
OpenSesame is a plug-and-play tool that detects AI hallucinations and improves response accuracy for companies using LLMs. Our platform leverages context-based information to detect hallucinations in LLMs with precision. By ensuring accurate and error-free text generation, we provide a reliable solution for enhancing AI outcomes. | Jul 01, 2025 | |
Latent Labs
|
Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today. | $40M / Series A / Feb 13, 2025 | |
Borderless AI
|
Borderless AI is a global payroll solution that leverages the power of generative AI to automate and speed up the process of on-boarding, managing, and paying international team members. Learn more at: hireborderless.ai | $5M / Seed / Jan 16, 2025 | |
|
Helical
|
Helical is an intermediary platform that offers bioinformaticians free access to the technologies from AI and biological computation. | $3.2M / Seed / Jun 28, 2024 | |
DatologyAI
|
DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation. | $11.7M / Seed / Feb 22, 2024 | |
|
Latent Labs
|
Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today. | $10M / Seed / Jan 01, 2024 | |
Finster AI
|
Finster AI offers AI agents that can read, analyse and integrate disparate sources of financial and market data. | $1.8M / Pre-Seed / Dec 31, 2023 | |
| See all 17 investments → | |||
Co-Investors
About Cohere
Cohere develops artificial intelligence solutions for enterprises, focusing on natural language processing and large language model deployments. The company offers API-based access to models that support tasks such as summarization, search, classification, and content generation. It enables organizations to integrate these models into internalsystems across regulated industries, including finance and healthcare. Cohere provides infrastructure that is cloud-agnostic and can be deployed on-premise or across public clouds. It also supports retrieval-augmented generation and offers tooling designed to align models with enterprise data and compliance needs. In addition to its core technology,
Cohere Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Aidan Gomez
Co-Founder & CEO
|
|||
Claire Cheng
Chief of Staff
|
|||
Ivan Zhang
Co-Founder
|
|||
Jaron Waldman
Product Advisor
|
|||
Laura Moss
VP of Finance
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Aidan Gomez invest in?
Aidan Gomez invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Seed and Pre-Seed stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Aidan Gomez's check size?
Aidan Gomez typically joins rounds of $2.8M–$12M at Seed and $1.8M–$3.5M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Aidan Gomez participates in.
How do I contact Aidan Gomez?
Public channels for Aidan Gomez include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Aidan Gomez last invest?
The most recent investment recorded for Aidan Gomez closed in Apr 2026. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
